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ABSTRACT 
In this current era of technology, industrialization and urbanization human beings have become more 
inclined towards unhealthy diet, sedentary lifestyle and stress which has given rise to various lifestyle related 
disorders of which Hypertension is of utmost significance. Considering its increasing prevalence and 
development of drug resistance a study related to clinical evaluation of Raktadabashamak Ghana Vati (a self 
formulated drug) consisting of Root of Jatamansi (Nordostachys jatamansi) - 1 part, Root of Gokshura 
(Tribulus terrestris) - 1 part, Stem Bark of Arjuna (Terminalia arjuna) - 1/2part, Whole herb of Brahmi 
(Bacopa monnireri) - 1 part. Root of Vacha (Acorus calamus) - 1/4 part, Root of Tagara (Valeriana wallichii) - 
1/2 part, was undertaken in 20 hypertensive patients for 2 months. Results obtained with Raktadabashamak 
Ghana Vati 2 tablets twice daily after meals with luke warm water on 18 patients were 18.6% relief in Systolic 
Blood Pressure, 18.5% relief in Diastolic Blood Pressure, 9.3% relief in Pulse rate, 18.8% relief in Pulse 
pressure, 19.05% relief in Mean Arterial Pressure which were all statistically highly significant. Overall 
response of Raktadabashamak Ghana vati was excellent in 17.6% patients and marked improvement in 
41.1%. These facts lead to the conclusion that Raktadabashamak Ghana vati can be a effective treatment for 
essential hypertension. Remission of treatment lead to increase in Blood pressure However, Study should be 
repeated by taking sample with longer duration to see whether the recurrence of disease in follow ups has 
decreased or not. 
KEYWORDS: Arjuna, Brahmi, Essential hypertension, Gokshura, Hypertension, Jatamansi, Raktadaba-
shamak Ghana vati, Tagar, Vacha. 
INTRODUCTION 
 In this current era of technology, industrialization 
and urbanization, human beings have become more 
inclined towards unhealthy diet, sedentary lifestyle and 
stress which has given rise to various lifestyle related 
disorders of which Hypertension is of utmost significance. 
Hypertension or high blood pressure, sometimes called 
arterial hypertension, is a chronic medical condition in 
which the blood pressure in the arteries is elevated. Blood 
pressure above 140/90 mmHg is mainly considered as 
hypertension. 
 In India overall prevalence have been found 
29.8% (27.6% in rural parts & 33.8% in urban parts).1 
ICMR & AIIMS study had declared India as Nation of 
hypertension2.  
 Considering its high prevalence and the fact that 
till now there is no permanent cure for hypertension an 
attempt has been made in our project “clinical evaluation 
of Raktadabashamak Ghana vati in the management of 
essential hypertension” to find a reliable, cost effective, 
safe and easy to administer Ayurvedic medicine. 
Objective 
 To evaluate the effect of Raktadabashamak Ghana 
vati on clinical and biochemical parameters of patient of 
essential hypertension. 
Materials and methods 
 Diagnosis was mainly based on 3 readings of 
sphygmomanometer. Both known cases of essential 
hypertension as well as newly diagnosed patients were 
included in the study as per classification of hypertension 
of 7th report of Joint National Committee(JNC)3.  
Constituents of ‘Raktadabashamaka Ghana Vati’ (self 
formulated)  
1. Root of Jatamansi (Nordostachys jatamansi) – 1 part 
2. Root of Gokshura (Tribulus terrestris) – 1 part 
3. Stem Bark of Arjuna (Terminalia arjuna) – 1/2part 
4. Whole herb of Brahmi (Bacopa monnireri) – 1 part 
5. Root of Vacha (Acorus calamus) – 1/4 part 
6. Root of Tagara (Valeriana wallichii) – 1/2 part 
 The drug was prepared by processing the Churna 
of raw drugs into Kwatha form (Churna + 8 times of water 
and heat upto 1/8 times remaining) which was then 
cooked in medium heat for conversion into Ghana form 
and then tablets were made after drying of Ghana part. 
Inclusion criteria 
 Age between 20 to 70 years. 
 Blood pressure – Systolic blood pressure – 140-179 
mmHg. 
Diastolic blood pressure -90-109mmHg 
Exclusion criteria 
 Patients having hypertension due to other secondary 
disease like renal disease, endocrinal disorder, 
Neurogenic causes, etc. 
 Patients having complication of hypertension. 
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 Any other serious medical & surgically ill patients. 
Investigations 
 Investigations were carried out to rule out 
secondary hypertension or any other pathologic condition. 
Hb%, TLC, DLC, ESR, BSL-F & PP, lipid profile, Blood urea, 
S.creatinine, urine R & M and ECG.  
Dose of Drug 
 2 tablets of Raktadabashamak Ghana vati (each 
tablet of 250 mg) were given orally twice daily after meal 
with luke warm water. 
Duration: Duration of clinical trial was of two months. 
Clinical assessment was done at 15 days interval. 
Pathya and Apathya (Do’s and Don’t’s) 
 All the patients in the trial were advised to reduce 
salt intake in their diet, avoid fatty and fried foods and 
include more vegetables and fruits in their diet, to stop 
addictions like smoking, alcohol if any and to do 
meditation for 30 minutes daily. 
Criteria for assessment 
A. Objective criteria : changes in blood pressure, pulse 
pressure, pulse rate and mean arterial pressure. 
B. Subjective criteria : changes in symptoms Shiroruja 
(headache), Hriddrava (palpitation), Bhrama (vertigo), 
Klama (fatigue), Akshiraga (Redness in eye), 
Krodhaprachurya (Irritability), Anidra (insomnia). All 
the symptoms were given suitable score.  
0 Normal 
1 Mild 
2 Moderate 
3 Severe 
4 Very severe 
The total effect of therapy was assessed by percentage of 
score reduction. 
Assessment score: percentage relief in signs and 
symptoms as follows: 
 Excellent response >75% 
 Marked response 50 to 75% 
 Mild response 25-50% 
 No response <25% 
Statistical analysis: Paired t test, was carried at the level 
of 0.05, 0.01, 0.001 of p level4. Thus the obtained results 
were interpreted as: 
P> 0.05 Not Significant 
P< 0.01 & <0.05 significant  
P< 0.001 highly significant 
OBSERVATIONS 
 In present research work, out of 20 registered 
patients 18 patients discontinued the treatment. 18 
patients completed the trial. Maximum number of patients 
were belonging to age group 51-60 years(23.3%) followed 
by age group 41-50 years(21.7%).majority of the patients 
were females(53.3%).61.7% of patients were residents of 
urban areas. majority of patients were of Vata-Pittaja 
prakriti(Physical constitution) (45%) and 46.7% were of 
lower middle class. lifestyle of 75% patients were 
sedentary and 35% patients had addiction of smoking. 
symptoms recorded in the patients were headache (12 
patients), vertigo (7 patients), palpitation (10 patients), 
fatigue (12 patients), insomnia (11 patients), Irritability 
(11 patients), Redness of eyes (11 patients). 
RESULTS  
Effect on Blood pressure: the mean systolic blood 
pressure before treatment was 153.7 mmHg which 
dropped by 18.6% to 124.94mmHg after 60 days. 
statistically this reduction in systolic blood pressure after 
2 months was highly significant (Table -1). 
 Similarly initial mean diastolic blood pressure was 
103.76 mmHg before treatment which reduced to 
84.4mmHg(18.5%) after 60 days. Statistically this 
reduction was also highly significant.(Table-1). 
Effect on pulse rate : mean pulse rate was 82.7/minute 
which reduced to 75/minute after completion of 
treatment. Overall percentage relief was 9.3% which was 
highly significant. (Table-1). 
Effect on Pulse pressure : mean pulse pressure before 
treatment was 49.88mmHg before treatment which got 
reduced to 40.4mmHg after completion of trial giving a 
highly significant percentage relief of 18.8%.(Table-1). 
Effect on mean arterial pressure: the mean arterial 
blood pressure before treatment was 120.39mmHg which 
dropped to 97.4mmHg after 60 days. Percentage relief was 
19.05% which was highly significant. (Table-1). 
Effect on the symptoms: 83.78% relief in Headache 
which was statistically highly significant, . Irritability was 
relieved by 75.8% which was also highly significant. 
Vertigo was relieved by 82.3% which was statistically 
highly significant. Insomnia was relieved by 80.7% which 
was also statistically highly significant. Palpitation was 
relieved by 70.8%, Fatigue was relieved by 64.5% which 
was statistically significant. Redness in eye was relieved by 
57.6% which was statistically significant. (Table-2). 
Overall effect of therapy: Assessment of overall effects of 
the drug was done based upon relief in blood pressure and 
the symptoms after 60 days of treatment. It was found out 
that 17.6% of patients showed excellent response and 
41.1% patient showed marked response. (Table-3). 
Dose related side effects: no side effects were observed 
in any patient during the study.  
Table 1: Effect of Raktadabashamak Ghana Vati in essential Hypertension 
Parameters Mean Score ± S.D % relief  ‘t’  P 
BT A1 A2 A3 A4 (AT) 
SBP 153.7±12.77 133.7±12.1 131.±12.1 129.5±12.6 124.94±14.6 18.6 9.3 <0.001 H.S 
DBP 103.76±7.8 76.35±6.2 90.82±10.2 87.05±12.7 84.4±12.88 18.5 6.9 <0.001 H.S 
Pulse Rate/min 82.7±4.64 79.9±3.29 76±3.80 76.5±4.72 75±6.07 9.3 5.84 <0.001 H.S 
Pulse pressure 49.88±8.9 43.64±13.3 41.1±7.4 42.2±6.8 40.4±6.9 18.8 6.26 <0.001 H.S 
MAP 120.39±8.7 104.5±12.3 104.4±10 101.1±12.2 97.4±12.3 19.05 7.65 <0.001 H.S 
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Table 2: Effect of therapy on symptoms 
Symptoms Mean Score ± S.D % relief ‘t’ P 
 BT A1 A2 A3 A4 (AT) 
Shiroruja (Headache) 2.11±1.6 1.4±0.97 0.88±1.1 0.35± 1.38 0.7±1.2 83.78 5.44 <0.001 HS 
Hrid drava 
(Palpitation) 
1.61±1.50 0.94±0.70 0.74±1.08 0.69±1.11 0.47±1.37 70.8 3.85 <0.01 
 
Klama(Fatigue) 1.72±1.31 1.27±0.51 1.11±0.60 0.78±0.93 0.61±10 64.5 3.73 <0.01 
Bhrama (Giddiness) 0.94±1.36 0.61±0.48 0.39±0.85 0.4±0.85 0.17±1.16 82.3 4.83 <0.001 HS 
Akshiraga (redness of 
eyes) 
1.55±1.46 1.27±0.46 0.72±1.15 0.55±1.08 0.67±1.05 57.6 3.91 <0.01 
Krodhaprachurya 
(Irritability) 
1.70±1.5 1.11±0.87 0.94±0.97 0.76±1.19 0.41±1.19 75.8 4.06 <0.001 HS 
Alpanidra (Reduced 
sleep) 
1.3±1.52 0.9±0.77 0.6±1.08 0.4±1.29 0.2±1.37 80.7 4.63 <0.001 HS 
Table 3: Overall effect of drug therapy with Raktadabashamak Ghana vati 
Overall effect of therapy No. of cases Percentage 
Excellent response 3 17.6% 
Marked response 7 41.1% 
Mild response 5 29.4% 
DISCUSSION 
1. 60 days treatment of Raktadabashamak Ghana Vati 
significantly reduced systolic and diastolic blood 
pressure within normal limits. SBP was reduced by 
18.6% from 153.7mmHg to 124.9mmHg. DBP was 
reduced by 18.5% from 103.7 to 84.4mmHg. 
2. The therapy significantly reduced mean pulse pressure 
by 18.8% from 49.8mmHg to 40.4mmHg and mean 
arterial pressure by 19.05% from 120.3mmHg to 
97.4mmHg. 
3. The therapy also significantly reduced pulse rate within 
normal limits from 82.7/min to 75/min. 
4. The therapy produced highly significant result in 
headache and insomnia, significant result in palpitation, 
fatigue, Redness in eyes, Irritability and Vertigo. 
5. Hence it can be concluded that Raktadabashamak 
Ghana vati brought significant changes in blood 
pressure and symptoms associated with essential 
hypertension and brought blood pressure to normal 
limits. 
6. Jatamansi is medhya (brain tonic) and Vaatnadishamak 
(sympatholytic) due to these actions it relaxes brain 
and nervous system and causes vasodilation. its 
chemical constituent Jatamansone is useful in cardiac 
arrhythmias5. Various clinical studies have shown its 
antihypertensive effect.6 
7. Gokshur is well known for its Mutral (diuretic effect) 
apart from this it also used in Hridrogas (cardiovascular 
disorders) in Ayurveda7. Clinical studies have shown its 
antihypertensive, antidepressant and anxiolytic 
activities8. 
8. Arjuna has been said as Hridya (cardio tonic) in 
Ayurvedic texts. It provides strength to cardiac muscles 
and stroke volume which in turn decreases heart rate9. 
the flavonoids components present in the bark of 
Arjuna tree have antioxidant properties10, so Arjuna 
bark powder is beneficial in ischemic heart diseases 
associated with oxidative stress. Studies have proven 
its cardio protective effects. It also shows anticoagulant 
property which can be used in coronary artery diseases 
and thus can reduce hypertension of cardiac origin. 11 
9. Brahmi in Ayurvedic medicine system is used as a 
powerful Medhya (brain tonic) drug as well as a 
memory enhancer. It is Balya (provides strength) to 
Vaatnadisansthan (nervine tonic).12 Brahmi extract 
bacosides have shown anxiolytic, antidepressant, 
antistress and antioxidant activity. 13 
10. Vacha is also used as Medhya drug in Ayurvedic 
medicine moreover, due to its Tikshna guna (sharp) it 
has a Lekhaniya action which is beneficial in high lipid 
profile. Studies have shown its blood pressure lowering 
and vascular modulator effects.14 
11. Tagara is mainly used in Ayurvedic medicine to treat 
nervousness, insomnia and heart palpitations, Shiro 
rogas (headaches) and Rakta vikaras (blood disorders). 
valerenic acid present in the herb has been shown to 
inhibit the breakdown of neurotransmitter GABA which 
results in sedation. Studies have also shown its 
antihypertensive, anxiolytic effect. 15 
12. Since essential hypertension is a multi factorial disease, 
treatment modalities should be based upon vitiated 
Vata dosha along with Pitta and Kapha. The drug 
formulations should have properties like Medhya 
(Nootropic), Hridya (Cardiotonic), Mutrala (Diuretic), 
Vatanadishamak (Nervine sedative), Manasadoshahara 
(Anti anxiety), Deepana and Pachana (Increase 
metabolic rate). 
13. Overall effect of Raktadabashamak Ghana Vati can be 
summarized as Tridoshashamaka (mainly Vata), 
Manasadoshahara, Vatanadishamaka, Hridya, Medhya, 
lekhaniya and mutrala. Due to wider range of action, 
Raktadabashamak Ghana Vati was more successful in 
reducing Blood pressure. 
14. Remission of treatment lead to increase in Blood 
pressure, which leads to fact that essential 
hypertension is a Yapya (Difficult to cure)disease. 
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CONCLUSION 
 Raktadabashamak Ghana Vati 2 tablets twice daily 
after meals with luke warm water on 18 patients were 
18.6% relief in Systolic Blood Pressure, 18.5% relief in 
Diastolic Blood Pressure, 9.3% relief in Pulse rate, 18.8% 
relief in Pulse pressure, 19.05% relief in Mean Arterial 
Pressure which were all statistically highly significant. 
Overall response of Raktadabashamak Ghana vati was 
excellent in 17.6% patients and marked improvement in 
41.1%. These facts lead to the conclusion that 
Raktadabashamak Ghana vati can be a effective treatment 
for essential hypertension. Remission of treatment lead to 
increase in Blood pressure. 
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